BusinessAlvogen CEO Robert Wessman speaks exclusively to World Finance about new opportunities in generic pharmaceuticalsBy Nasdaq OMXJan 22, 2018, 10:04 AM UTC
BusinessPhase 1b/2 Study of Margetuximab in Combination with Pembrolizumab Presented at 2018 ASCO Gastrointestinal Cancers SymposiumBy Nasdaq OMXJan 18, 2018, 7:00 PM UTC
BusinessCannabis Science Announces an Overwhelming Response to its Groundbreaking Research on the Use of Cannabinoids in the Treatment of Cancers, Already Has More Views Than 91% of the Papers Published in all Frontiers JournalsBy Nasdaq OMXJan 18, 2018, 1:23 PM UTC
BusinessInnovative Humanized Research Strategies for Immuno-Oncology Drug Development, Crown Bioscience Hosts a Live WebinarBy Nasdaq OMXJan 17, 2018, 1:01 PM UTC
BusinessArbutus Announces Closing of the Second Tranche of a $116M Strategic Investment from Roivant SciencesBy Nasdaq OMXJan 16, 2018, 1:30 PM UTC
BusinessPetMed Express D/B/A 1-800-PetMeds to Announce Its Third Quarter Financial Results on January 22, 2018By Nasdaq OMXJan 16, 2018, 1:01 PM UTC
